McKesson Co. (NYSE:MCK) Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC decreased its holdings in McKesson Co. (NYSE:MCK) by 2.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 37,861 shares of the company’s stock after selling 1,102 shares during the period. Thompson Siegel & Walmsley LLC’s holdings in McKesson were worth $21,577,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of MCK. Assetmark Inc. increased its holdings in shares of McKesson by 10.8% during the 3rd quarter. Assetmark Inc. now owns 6,884 shares of the company’s stock worth $3,403,000 after buying an additional 670 shares during the last quarter. Axxcess Wealth Management LLC increased its holdings in shares of McKesson by 198.7% during the 3rd quarter. Axxcess Wealth Management LLC now owns 2,055 shares of the company’s stock worth $1,016,000 after buying an additional 1,367 shares during the last quarter. Apollon Wealth Management LLC increased its holdings in shares of McKesson by 9.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 7,576 shares of the company’s stock worth $3,746,000 after buying an additional 671 shares during the last quarter. WealthPLAN Partners LLC increased its holdings in shares of McKesson by 4.3% during the 3rd quarter. WealthPLAN Partners LLC now owns 1,421 shares of the company’s stock worth $702,000 after buying an additional 58 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of McKesson by 0.5% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 320,207 shares of the company’s stock worth $158,317,000 after buying an additional 1,725 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction on Friday, February 14th. The shares were sold at an average price of $600.66, for a total transaction of $5,382,514.26. Following the completion of the sale, the chief executive officer now directly owns 69,625 shares of the company’s stock, valued at approximately $41,820,952.50. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Leann B. Smith sold 188 shares of McKesson stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares of the company’s stock, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 18,689 shares of company stock valued at $11,187,351. Insiders own 0.11% of the company’s stock.

McKesson Stock Down 1.9 %

Shares of MCK stock opened at $640.93 on Thursday. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $663.61. The stock has a market capitalization of $80.32 billion, a PE ratio of 29.35, a P/E/G ratio of 1.29 and a beta of 0.52. The firm has a 50 day moving average of $605.54 and a two-hundred day moving average of $569.47.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Analysts expect that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a dividend of $0.71 per share. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.44%. McKesson’s dividend payout ratio (DPR) is currently 13.00%.

Analyst Ratings Changes

A number of analysts have recently issued reports on MCK shares. Morgan Stanley raised their price target on shares of McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. StockNews.com downgraded shares of McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Citigroup dropped their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Bank of America dropped their target price on shares of McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Mizuho started coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 target price for the company. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $645.79.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.